We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
0 hedge funds and large institutions have $0 invested in ESSA Pharma in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
47.61% less ownership
Funds ownership: 47.61% → 0% (-48%)
100% less funds holding
Funds holding: 32 → 0 (-32)
100% less capital invested
Capital invested by funds: $4.3M → $0 (-$4.3M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 32
Holders
–
Holders Change
-32
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
32
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$2.23M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$833K |
| 3 |
Morgan Stanley
New York
|
-$364K |
| 4 |
P
Pfizer
New York
|
-$320K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$113K |
